Beximco Pharma's London bourse listing shifted for present situation
Beximco Pharmaceuticals Limited Monday announced that its offering of global depository receipt (GDR) on the London capital market, scheduled for end-July, has been shifted to September 2005.
bdnews24.com News Service
bdnews24.com
Published :
24 Jul 2005, 06:00 PM
Updated :
18 Aug 2022, 11:46 AM
Dhaka, July 25 (BDNEWS) - Beximco Pharmaceuticals Limited Monday announced that its offering of global depository receipt (GDR) on the London capital market, scheduled for end-July, has been shifted to September 2005.
The pharmaceutical heavyweight in a statement said that the decision was taken on the advice of Libertas Capital Group plc, the nominated adviser and broker of Beximco Pharmaceuticals.
"The change has been made in view of the current situations obtaining in London," said the corporate statement.
It said that the decision has been communicated to the Securities and Exchange Commission and Dhaka and Chittagong stock exchanges.
On June 2, 2005, Beximco Pharmaceuticals had unveiled an ambitious plan to raise UK£30 million and use the new money to add new manufacturing lines, new processes, repay foreign currency loans and fund rising costs.
BDNEWS/1713 hrs